Delivery Order SPE2DB22D2206-SPE2DB24FGL89
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $4,647.12 contract is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a specialty medical product. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,994.61 firm fixed-price delivery order is for the procurement of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical supply item. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $6,397.42 firm fixed-price delivery order is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical supply item. The contract has an ultimate completion date of October 4, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued at up...
- This federal contract award is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $4,647.12 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The award is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through 2025....
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $11,463.41 Firm Fixed Price Delivery Order is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product. The award is not associated with any set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distribution company that holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $4,711.64 firm fixed price delivery order is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product. This award is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that enables Amerisourcebergen Drug Corp to provide a comprehensive range...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a global pharmaceutical sourcing and distribution company. The $4,647.12 firm fixed price delivery order is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product. The award is not associated with any set-aside designation. Amerisourcebergen Drug Corporation, through its Corporate Office division located in Conshohocken, Pennsylvania, serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML. The $13,856.75 firm-fixed-price delivery order contract has an ultimate completion date of July 18, 2024. Amerisourcebergen is the prime contractor, and there is no set-aside designation for this award. This contract is likely part of a larger Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the leading global pharmaceutical sourcing and distribution company Amerisourcebergen Corporation. The $4,647.12 firm fixed price delivery order is for the supply of Monovisc 88 mg/4 ml syringes, a specialized pharmaceutical product. This award is under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with a potential value of $999,999,999.00...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical supplier to the U.S. government. The $4,647.12 firm fixed-price delivery order is for 4,564,437,255 units of the MONOVISC 88 MG/4 ML SYRINGE 4ML product, with a completion date of April 30, 2024. The contract has no set-aside designation. Amerisourcebergen, a subsidiary of the larger Cencora, Inc. parent company, holds a significant...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FGL89Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $4,647.12 firm fixed price delivery order is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a specialty pharmaceutical product. The award is associated with a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense worldwide. No set-aside designation was used for this contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 4/3/24 |